Cartwright K A, Stuart J M, Robinson P M
Gloucester Public Health Laboratory.
Epidemiol Infect. 1991 Feb;106(1):133-41. doi: 10.1017/s0950268800056491.
Between 1 October 1986 and 31 March 1987, 55 cases of meningococcal disease were identified in the South-West of England, an attack rate of 1.54 per 100,000 during the study period. Antibiotics used in the treatment of the disease successfully eliminated nasopharyngeal carriage of meningococci in 13 out of 14 cases without use of rifampicin. The overall meningococcal carriage rate in 384 close contacts was 18.2% and the carriage rate of strains indistinguishable from the associated case strain was 11.1%. The carriage rate of indistinguishable strains in household contacts (16.0%) was higher than the carriage rate in contacts living at other addresses (7.0%, P less than 0.05). A 2-day course of rifampicin successfully eradicated meningococci from 46 (98%) of 47 colonized contacts. In one third of cases groupable meningococci were isolated from at least one household contact; 92% of these isolates were of the same serogroup as the associated case strain. When a meningococcus is not isolated from a deep site in a clinical case of meningococcal disease, culture of serogroup A or C strains from nasopharyngeal swabs of the case or of household contacts is an indication that the close contact group should be offered meningococcal A + C vaccine in addition to chemoprophylaxis. The failure in this and other studies to isolate meningococci from any household contact in the majority of cases may be due either to the relative insensitivity of nasopharyngeal swabbing in detecting meningococcal carriage or to the acquisition of meningococci by most index cases from sources outside the household.
1986年10月1日至1987年3月31日期间,英格兰西南部确诊了55例脑膜炎球菌病病例,研究期间的发病率为每10万人中有1.54例。在14例未使用利福平治疗的病例中,有13例使用治疗该病的抗生素成功消除了鼻咽部脑膜炎球菌带菌状态。384名密切接触者的总体脑膜炎球菌带菌率为18.2%,与相关病例菌株无法区分的菌株带菌率为11.1%。家庭接触者中无法区分的菌株带菌率(16.0%)高于居住在其他地址的接触者(7.0%,P<0.05)。利福平的2天疗程成功地从47名带菌接触者中的46名(98%)身上根除了脑膜炎球菌。在三分之一的病例中,从至少一名家庭接触者身上分离出了可分组的脑膜炎球菌;这些分离株中有92%与相关病例菌株属于同一血清群。当在脑膜炎球菌病临床病例的深部部位未分离到脑膜炎球菌时,从病例或家庭接触者的鼻咽拭子中培养A群或C群菌株表明,除了化学预防外,还应向密切接触组提供A+C群脑膜炎球菌疫苗。在本研究及其他研究中,大多数病例的任何家庭接触者均未分离到脑膜炎球菌,这可能是由于鼻咽拭子检测脑膜炎球菌带菌状态的相对不敏感性,或者是由于大多数指示病例是从家庭外部来源感染脑膜炎球菌的。